z-logo
open-access-imgOpen Access
[Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
Author(s) -
Lishuai Xu,
Weidong Li,
Qian Shi,
Minfeng Wang,
Heng Li,
Xiaoli Yang,
Junjun Zhang
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8389
Subject(s) - pi3k/akt/mtor pathway , editorial board , audience measurement , cancer research , microrna , oncogene , retinoblastoma , protein kinase b , medicine , cancer , cell cycle , library science , biology , apoptosis , political science , computer science , genetics , gene , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom